Back HIV/AIDS HIV/AIDS Topics HIV Treatment IDWeek 2013: Studies Look at Community vs Hospital-based HIV Care and Medication Issues

IDWeek 2013: Studies Look at Community vs Hospital-based HIV Care and Medication Issues

alt

HIV positive people treated at community clinics were more likely to continue receiving care, while those treated at hospital clinics were more likely to maintain undetectable viral load, researchers reported at IDWeek 2013 this week in San Francisco. Other studies found that people with HIV often take many drugs for various conditions and a multidisciplinary team of experts can help prevent medication errors.

 

Community vs Hospital Clinics

 

Asher Schranz from New York University and colleagues compared outcomes among people with HIV receiving care in different settings. Community clinics may have advantages such as culturally competent care targeted to specific populations, while hospitals may offer more specialty care and better management of comorbid conditions.

This retrospective cohort study included 13,027 HIV positive patients receiving care at 25 Ryan White-funded clinics in Philadelphia between January 2008 and December 2011. The 12 hospital-based clinics saw 61% of patients and the 13 community-based clinics saw 39%. People who received care at multiple clinics and those still in their first year of care were excluded from the analysis.

The 2008 sample included 6434 people and the 2011 sample included 10,037 people (some were in both groups). Nearly two-thirds were men, about one-third were age 50 or older, and about 65% were black. Nearly half were in the heterosexual transmission risk group, about 30% were men who have sex with men, and approximately 17% had a history of injection drug use. Most were low-income, with about 60% having a household income below $10,000/year. About one-third had a CD4 T-cell count below 350 cells/mm3, the threshold for starting treatment during most of the study.

The researchers compared characteristics of patients seen at community-based versus hospital-based clinics, assessed changes over time, and compared outcomes including retention in care (defined as 2 visits at least 90 days apart), use of antiretroviral therapy (ART), and viral load suppression.

Results

  • Looking at changes over time, the percentage retained in care rose from 79% in 2008 to 85% in 2011.
  • Use of ART also increased from 83% to 88%.
  • Viral suppression saw the largest gain, from 64% to 78%.
  • Women and people with higher incomes were more likely to use hospital-based clinics, while community-based clinic patients were more likely to be on Medicaid or Medicare, rely on Ryan White funding, or be uninsured.
  • People attending community-based clinics were significantly more likely than hospital clinic patients to be retained in care: 85% vs 82%, respectively.
  • Use of ART was similar in both groups (86% vs 87%), but hospital clinic patients were significantly more likely to achieve viral suppression (71% vs 76%).

"Community clinics have higher proportions of patients retained in care," the researchers concluded. "Patients in hospital clinics are more likely to be virally suppressed despite similar rates of ART use between clinic types."

They noted that this study focused on Ryan White-funded clinics in an urban setting, and the results might not be generalizable to other types of healthcare facilities.

Polypharmacy

Jennifer Edelman from Yale University and colleagues looked at "polypharmacy," or use of multiple drugs for various conditions, among people with HIV, as well as the association between polypharmacy and risk of death.

This cross-sectional analysis (October 2009 to September 2010) included 16,989 HIV positive patients on ART and 47,613 matched HIV negative control subjects in the US Veterans Aging Cohort Study, which maintains extensive electronic medical and pharmacy records. People with no visits in the past year, those with a cancer diagnosis at baseline, those with no dispensed medications, and HIV positive people not on ART were excluded.

Almost all patients were men, the average age was about 55 years, 47% were black, and 40% were white. In the HIV positive group the median CD4 count was 322 cells/mm3, 56% were taking protease inhibitors, and 44% were on NNRTIs.

People with HIV were on a median of 3.49 drugs compared 4.23 for HIV negative people, counting long-term outpatient medications other than antiretrovirals. HIV positive people were more likely to be on 0-3 drugs (~35% vs ~44%) and about equally likely to be on 4-6 drugs (~30%), but less likely to be taking 7-9 drugs (~18% vs ~15%), 10-12 drugs (~8% vs ~5%), or more than 12 drugs (~5% vs ~3%).

Among both HIV positive and HIV negative people, the most frequent comorbid conditions were hypertension, diabetes, severe mental illness, substance use disorders, cardiovascular disease, and chronic obstructive pulmonary disease (COPD). All but substance use were more common in the HIV negative group.

The most frequently used medications (besides antiretrovirals) were lipid-lowering drugs, ACE inhibitors, gastric medications, anti-depressants, beta bockers, non-opioid analgesics, calcium channel blockers, diuretics, diabetes drugs, and genitourinary medications -- all of which were used more often by HIV negative people.

Being HIV positive, male, and black or Hispanic were associated with fewer drugs, while having diabetes, COPD, cardiovascular disease, or hypertension were associated with more drugs. However, people with kidney disease or liver cirrhosis were on fewer drugs, perhaps because these conditions affect drug processing and can lead to worse side effects or interactions.

Use of multiple medications was associated with a higher risk of death for both HIV positive and negative people. Patients taking more than 5 non-ART drugs had a 30% higher all-cause mortality rate, and for each medication beyond 5 mortality rose by 5% in an adjusted analyses. This increase in mortality was greater for people with HIV.

"Treated HIV-infected patients are commonly exposed to polypharmacy," but "are less likely to be prescribed non-ART medications" than HIV negative people, the researchers concluded.

"Future studies examining longitudinal associations with polypharmacy and mortality and other health outcomes are warranted," they recommended. "The development and evaluation of interventions to reduce polypharmacy among HIV-infected patients are needed."

Reducing Medication Errors

Finally, Elizabeth Neuner and colleagues from the Cleveland Clinic evaluated a multidisciplinary program intended to reduce ART or opportunistic infection medication errors in an inpatient hospital setting. This included pharmacy education, changes to electronic pharmacy records, an optimized physician order entry system, and daily medication reviews by an infectious disease specialist.

This retrospective analysis compared 162 patients admitted before (January to October 2011) and 110 admitted after (July to December 2012) implementation of these interventions. Admissions could be for HIV-related care or any other condition.

The most common types of medication errors before the interventions involved prescribing combinations that resulted in drug interactions, incorrect frequency of administration, prescribing incomplete regimens, failing to adjust dosing for conditions such as kidney impairment, and over-dosing or under-dosing.

The researchers found that the rate of medication errors fell significantly, from 50% of all admissions in 2011 to 34% in 2012. The mean number of errors also dropped from 1.5 to 1.2 per patient. In addition, the likelihood of resolving errors rose from 36% to 74%, and the time it took to do so fell from a median of 180 to 23 hours. Patients who received an infectious disease consultation had a significantly higher likelihood of error resolution (68% vs 32%).

"Multifaceted, multidisciplinary stewardship was able to significantly reduce the rate of medical errors and increase the rate of resolution," Neuner summarized at an IDWeek press conference.

HIV is now mainly an outpatient disease and many providers working in inpatient settings are not familiar with ART, HIV Medicine Association chair Michael Horberg noted at the presssr. This study "adds to the increasing body of evidence supporting expert care in inpatient as well as outpatient settings."

10/4/13

References

A Schranz, KBrady, S Keller, et al. Outcomes Differ for HIV-Infected Patients Receiving Care at Hospital vs. Community-Based Clinics. 2nd ID Week Conference (IDWeek 2013). San Francisco. October 2-6, 2013. Abstract 77.

J Sanders, A Pallotta, S Bauer, E Neuner, et al. Antiretroviral Medication Errors in Hospitalized Patients with HIV. 2nd ID Week Conference (IDWeek 2013). San Francisco. October 2-6, 2013. Abstract 176.

EJ Edelman, K Gordon, K Akgun, AC Justice, et al. HIV+ Individuals on ART Are at Risk of Polypharmacy: More Medication Increases Mortality. 2nd ID Week Conference (IDWeek 2013). San Francisco. October 2-6, 2013. Abstract 76.

Other Source

IDWeek. Hospitalized HIV Patients Benefit from Seeing Infectious Disease Specialists. Press release. October 3, 2013.